Jones Trading on ORIC Pharmaceuticals (ORIC): "We see pressure" following Ipsen's Tazverik withdrawal
Tweet Send to a Friend
Jones Trading analyst Soumit Roy reiterated a Buy rating and $25.00 price target on ORIC Pharmaceuticals (NASDAQ: ORIC)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
